M

Researcher Profile

Mohan Hingorani

🏛 Hull University Teaching Hospitals NHS Trust, Hull, UK

3

Publications

421

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article BMJ Open Dec 01, 2024

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial

Finbar Slevin · Sophie Alexander · Sarah R Brown · Matthew Carter +19 more

10.1136/bmjopen-2024-095560 9 citations

Open Access Journal Article The Lancet Oncology Mar 01, 2023

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Janet E Brown · Kara-Louise Royle · Walter Gregory · Christy Ralph +94 more

10.1016/s1470-2045(22)00793-8 74 citations

Open Access Journal Article The Lancet Jan 01, 2022

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard · Laura Murphy · Noel W Clarke · William Cross +149 more

10.1016/s0140-6736(21)02437-5 338 citations

Publication Timeline

2024

1

2023

1

2022

1

Frequent Co-Authors

Narayanan Srihari

Stergios Boussios